These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 19837912

  • 21. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
    Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR.
    Ann N Y Acad Sci; 2006 Nov; 1088():265-73. PubMed ID: 17192572
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C.
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [Abstract] [Full Text] [Related]

  • 24. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
    Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M, Mikhailidis DP.
    Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vitamin A regulates hypothalamic-pituitary-adrenal axis status in LOU/C rats.
    Marissal-Arvy N, Hamiani R, Richard E, Moisan MP, Pallet V.
    J Endocrinol; 2013 Oct; 219(1):21-7. PubMed ID: 23847298
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [Abstract] [Full Text] [Related]

  • 34. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA, Turban S, Battle JH, Chapman KE, Seckl JR, Morton NM.
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [Abstract] [Full Text] [Related]

  • 35. Will treating diabetes with 11β-HSD1 inhibitors affect the HPA axis?
    Harno E, White A.
    Trends Endocrinol Metab; 2010 Oct; 21(10):619-27. PubMed ID: 20594868
    [Abstract] [Full Text] [Related]

  • 36. Local cortisol/corticosterone activation in skin physiology and pathology.
    Terao M, Katayama I.
    J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
    [Abstract] [Full Text] [Related]

  • 37. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
    Park SB, Jung WH, Kang NS, Park JS, Bae GH, Kim HY, Rhee SD, Kang SK, Ahn JH, Jeong HG, Kim KY.
    Eur J Pharmacol; 2013 Dec 05; 721(1-3):70-9. PubMed ID: 24135201
    [Abstract] [Full Text] [Related]

  • 38. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T.
    J Clin Endocrinol Metab; 2002 Jul 05; 87(7):3330-6. PubMed ID: 12107245
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.